BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 328335)

  • 1. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of suckling on serum prolactin, luteinizing hormone, follicle-stimulating hormone, and estradiol during prolonged lactation.
    Battin DA; Marrs RP; Fleiss PM; Mishell DR
    Obstet Gynecol; 1985 Jun; 65(6):785-8. PubMed ID: 3923412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of puerperal lactation by bromocriptine.
    Rolland R; Schellekens LA
    Acta Endocrinol Suppl (Copenh); 1978; 216():119-30. PubMed ID: 347857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metergoline as an inhibitor of prolactin release.
    Caballero A; Mena P; Caballero-Díaz JL; Caballero-Asensi A
    J Reprod Med; 1987 Feb; 32(2):115-9. PubMed ID: 3560070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal prolactin levels and pituitary-gonadal axis in the puerperium.
    Andersen AN; Tabor A; Hertz JB; Schiøler V
    Obstet Gynecol; 1981 Jun; 57(6):725-9. PubMed ID: 7231824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].
    Walker S
    Br J Clin Pharmacol; 1975 Aug; 2(4):368P-369P. PubMed ID: 788734
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
    Bohnet HG; Kato K; De Moll H
    Obstet Gynecol; 1988 Jan; 71(1):53-5. PubMed ID: 3336541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between maternal prolactin levels during pregnancy and lactation in women with pituitary adenoma.
    Narita O; Kimura T; Suganuma N; Osawa M; Mizutani S; Masahashi T; Asai M; Tomoda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):758-62. PubMed ID: 3998551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prolactin secretion during normal pregnancy and puerperium, particularly with regard to nursing (author's transl)].
    Wada Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):891-8. PubMed ID: 6787151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of prolactin on the hypothalamo-pituitary-ovarian axis in puerperium].
    Fukuiya T
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):571-8. PubMed ID: 6425435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Lisuride on serum prolactin levels during puerperium.
    Venturini PL; Maganza C; Massimilla A; Campanella P; Rossato P; Ragni N; De Cecco L
    Acta Eur Fertil; 1979 Jun; 10(2):51-5. PubMed ID: 545976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hormone changes in parturients given steroid preparations to suppress lactation.
    Lev-Gur M; Rodriguez LJ; Smith KD; Steinberger E
    Int J Fertil; 1990; 35(2):95-9. PubMed ID: 1970984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactation suppression with bromocriptine.
    Hutchison P; Sill H
    N Z Med J; 1981 Oct; 94(694):309-10. PubMed ID: 7033847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metergoline as a lactation inhibitor.
    Caballero A; Palomo A; Molina CE; Albarrán FJ; Caballero A; Mena P
    J Reprod Med; 1982 Apr; 27(4):202-6. PubMed ID: 7097670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum prolactin levels during inhibition of lactation with 2-brom-alpha-ergocryptin (CB 154) (author's transl)].
    Gerstner G; Mick R; Spona J
    Wien Klin Wochenschr; 1977 Oct; 89(19):664-7. PubMed ID: 910447
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormonal limitation of lactation (author's transl)].
    Momberg M; Schneider L
    Z Geburtshilfe Perinatol; 1976 Feb; 180(1):84-7. PubMed ID: 773016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of lactation with lisuride.
    Hardt W; Schmidt-Gollwitzer M; Horowski R
    Gynecol Obstet Invest; 1979; 10(2-3):95-105. PubMed ID: 535777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an injectable cabergoline formulation on serum prolactin (PRL) and milk secretion in early postpartum Beagle bitches.
    Romagnoli S; Milani C; Perin S; Ballabio R; Stelletta C; Mollo A; Gelli D
    Reprod Domest Anim; 2009 Jul; 44 Suppl 2():148-51. PubMed ID: 19754555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline.
    Melis GB; Mais V; Paoletti AM; Beneventi F; Gambacciani M; Fioretti P
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):311-4. PubMed ID: 3279351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.